Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986206 · ClinicalTrials.gov registry record
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
A clinical trial, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- 525
- Enrollment target
NCT00986206: Completed study, sponsored by Women and Infants Hospital of Rhode Island.
NCT00986206 is a clinical trial that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 525 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00986206 has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- 525 participants
- Enrollment target
Study Summary
RATIONALE: Screening tests, such as the lysophosphatidic acid assay, may help doctors find cancer cells early and plan better treatment for ovarian cancer. PURPOSE: This clinical trial is studying using the lysophosphatidic acid assay to see how well it works in early detection of ovarian cancer in patients with ovarian cancer or who are at risk for ovarian cancer.
Primary Outcome
To develop a serum or plasma based assay to quantitate LPA levels
Interventions
- DIAGNOSTIC_TEST Biomarker LPA and HE4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2009-06 |
| Est. Completion | 2015-07 |
What the finished NCT00986206 record still lists
NCT00986206 is an observational study that tracks outcomes without assigning an intervention. The registered 525 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Biomarker LPA and HE4 is the first listed.
NCT00986206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00986206 about?
NCT00986206 is a clinical study titled "Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer". RATIONALE: Screening tests, such as the lysophosphatidic acid assay, may help doctors find cancer cells early and plan better treatment for ovarian cancer. PURPOSE: This clinical trial is studying using the lysophosphatidic acid assay to see how well it works in early detection of ovarian cancer in...
What is the current status of trial NCT00986206?
This trial is currently completed. The enrollment target is 525 participants. The study started on 2009-06. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00986206?
The interventions under investigation include: Biomarker LPA and HE4 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00986206?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04769492 · 525 participants · NA
#ChopViolence/#ChopHIV
- NCT05260047 · 525 participants · NA
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
- NCT05620719 · 525 participants · NA
Multisite Advancement of Research on Chronic Posttraumatic Headache
- NCT06496646 · 525 participants · NA
Antidepressant Adherence for Depressed Adults in Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia